Table 1 Participants characteristics (N = 196)
Characteristics | n (%), M ± SD (IQR) | ||
|---|---|---|---|
Having no nutritional risk n1 = 125 | Having nutritional risk n2 = 71 | Full Sample N = 196 | |
Age | 56.58 ± 6.52 (50–83) | 61.67 ± 9.26 (50–85) | 58.41 ± 7.99 (50–85) |
Gender | |||
 Male | 112 (57.14) | 62 (31.63) | 174 (88.77) |
 Female | 13 (6.63) | 9 (4.59) | 22 (11.22) |
Ethnicity | |||
 Han | 125 (63.78) | 69 (35.20) | 194 (98.98) |
 Minority | 0 (0.00) | 2 (1.02) | 2 (1.02) |
Education attainment | |||
 Primary school of below | 28 (14.29) | 21 (10.71) | 49 (25.00) |
 Secondary school | 48 (24.49) | 29 (14.80) | 77 (39.29) |
 Post-secondary | 40 (20.41) | 19 (9.69) | 59 (30.10) |
 University or above | 9 (4.59) | 2 (1.02) | 11 (5.61) |
Marital status | |||
 Married | 113 (57.65) | 57 (29.08) | 170 (86.73) |
 Single | 12 (6.12) | 14 (7.14) | 26 (13.27) |
Employment (Yes) | 55 (28.06) | 18 (9.18) | 73 (37.24) |
Disclosure of HIV Status (Yes) | 78 (39.80) | 50 (25.51) | 128 (65.31) |
Years since HIV diagnosis | 4.10 ± 3.19 (0–15) | 2.69 ± 1.72 (0–15) | 3.61 ± 2.86 (0–15) |
Prescribed ART in admission (Yes) | 78 (39.80) | 32 (16.33) | 110 (56.12) |
Years of ART use | 3.57 ± 3.12 (0–10) | 2.31 ± 1.87 (0–10) | 3.14 ± 2.82 (0–15) |
ART regimen | |||
 TDF-based regimen | 50 (25.51) | 15 (7.65) | 65 (33.16) |
 AZT-based regimen | 4 (2.04) | 1 (0.51) | 5 (2.55) |
 LPV/r-based regimen | 29 (14.80) | 11 (5.61) | 40 (20.41) |
Presence of comorbidities | 98 (50.00) | 61 (31.12) | 159 (81.12) |
 Pneumonia | 28 (14.29) | 27 (13.78) | 55 (28.06) |
 Hepatitis | 7 (3.57) | 2 (1.02) | 9 (4.59) |
 Tuberculosis | 4 (2.04) | 4 (2.04) | 8 (4.08) |
 Diabetes | 4 (2.04) | 3 (1.53) | 7 (3.57) |
 Syphilis | 5 (2.55) | 2 (1.02) | 7 (3.57) |
 Cancer | 6 (3.06) | 0 (0.00) | 6 (3.06) |
 Hypertension | 3 (1.53) | 0 (0.00) | 3 (1.53) |
 Chronic Diarrheal | 0 (0.00) | 2 (1.02) | 2 (1.02) |
CD4+ T cell count | |||
 0–50 | 14 (7.14) | 27 (13.78) | 41 (20.92) |
 51–250 | 62 (31.63) | 30 (15.31) | 92 (46.94) |
 251–500 | 29 (14.80) | 12 (6.12) | 41 (20.92) |
  > 501 | 20 (10.20) | 2 (1.02) | 22 (11.22) |
Viral load (RNA) | |||
  < 500 | 111 (56.63) | 68 (34.69) | 179 (91.33) |
  > 500 | 14 (7.14) | 3 (1.53) | 17 (8.67) |
Length of in-hospital stay | 11.86 ± 8.90 (1–45) | 16.15 ± 10.28 (2–56) | 13.42 ± 9.62 (1–56) |
BMI | |||
  < 17 | 1 (0.51) | 17 (8.67) | 18 (9.18) |
 17–18.5 | 8 (4.08) | 14 (7.14) | 22 (11.22) |
 18.5–25 | 101 (51.53) | 40 (20.41) | 141 (71.94) |
  ≥ 25 | 15 (7.65) | 71 (36.22) | 15 (7.65) |
Albumin | |||
  < 35 | 27 (13.78) | 40 (20.41) | 67 (34.18) |
  ≥ 35 | 98 (50.00) | 31 (15.82) | 129 (65.82) |
Prealbumin | |||
  < 200 | 62 (31.63) | 58 (29.59) | 120 (61.22) |
  ≥ 200 | 63 (32.14) | 13 (6.63) | 76 (38.78) |